SECURITIES AND EXCHANGE COMMISSION
UNDER
THE SECURITIES ACT OF 1933
|
Delaware
(State or other jurisdiction of
incorporation or organization) |
| |
26-2540421
(I.R.S. Employer
Identification Number) |
|
Malvern, PA 19355
(484) 875-3192
President and Chief Executive Officer
Annovis Bio, Inc.
101 Lindenwood Drive, Suite 225
Malvern, PA 19355(484) 875-3192
Mitchell S. Nussbaum, Esq.
Joan S. Guilfoyle, Esq.
Loeb & Loeb LLP
345 Park Avenue
New York, NY 10154
(212) 407-4000
|
Large accelerated filer
☐
|
| |
Accelerated filer
☐
|
|
|
Non-accelerated filer
☒
|
| |
Smaller Reporting Company
☒
|
|
| | | |
Emerging Growth Company
☒
|
|
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 12 | | | |
| | | | 19 | | | |
| | | | 20 | | | |
| | | | 21 | | | |
| | | | 24 | | | |
| | | | 24 | | | |
| | | | 24 | | |
INCORPORATION BY REFERENCE
Preferred Stock
Debt Securities
Warrants
Units
| | |
Amount to
be paid |
| |||
SEC registration fee
|
| | | $ | 9,848 | | |
FINRA filing fee
|
| | |
|
(1)
|
| |
Printing expenses
|
| | |
|
(1)
|
| |
Accounting fees and expenses
|
| | |
|
(1)
|
| |
Legal fees and expenses
|
| | |
|
(1)
|
| |
Miscellaneous
|
| | |
|
(1)
|
| |
Total
|
| | |
|
(1)
|
| |
|
Exhibit
Number |
| |
Description of Exhibit
|
|
|
1.1*
|
| | Form of Underwriting Agreement | |
|
4.1
|
| | | |
|
4.2*
|
| | Form of warrant agreement and any warrant certificate, if any. | |
|
4.3*
|
| | Form of Preferred Stock Certificate, if any | |
|
4.4*
|
| | Certificate of designation for preferred stock, if any. | |
|
4.5
|
| | |
|
Exhibit
Number |
| |
Description of Exhibit
|
|
|
4.6*
|
| | Form of Debt Securities, if any | |
|
4.7*
|
| | Form of Unit Agreement, if any | |
|
5.1
|
| | Opinion of Loeb & Loeb LLP regarding the legality of securities being registered** | |
|
23.1
|
| | | |
|
23.2
|
| | Consent of Loeb & Loeb LLP (included in Exhibit 5.1) | |
|
24.1
|
| | | |
|
25.1***
|
| | Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of a trustee acceptable to the registrant, as trustee under the Indenture with respect to senior debt securities. | |
|
107
|
| | |
| | | | ANNOVIS BIO, INC. | | |||
| | | | By: | | |
/s/ MARIA MACCECCHINI
Maria Maccecchini
President and Chief Executive Officer |
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Maria Maccecchini
Maria Maccecchini
|
| | President and Chief Executive Officer (principal executive officer) | | |
February 1, 2024
|
|
|
/s/ Henry Hagopian III
Henry Hagopian III
|
| |
Chief Financial Officer (principal financial and accounting officer) |
| |
February 1, 2024
|
|
|
/s/ Michael Hoffman
Michael Hoffman
|
| | Chairman of the Board and Director | | |
February 1, 2024
|
|
|
/s/ Claudine Bruck
Claudine Bruck
|
| | Director | | |
February 1, 2024
|
|
|
/s/ Reid McCarthy
Reid McCarthy
|
| | Director | | |
February 1, 2024
|
|
|
/s/ Mark White
Mark White
|
| | Director | | |
February 1, 2024
|
|
Attachments
Disclaimer
Annovis Bio Inc. published this content on 01 February 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 February 2024 21:06:53 UTC.